Max Peters
Utrecht University
69 Papers
242 Citations
Max Peters is an academic researcher from Utrecht University. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 16, co-authored 68 publications. Previous affiliations of Max Peters include University Medical Center Utrecht.
Chat about Author
Papers
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
Stephanie Guillaumier,Stephanie Guillaumier,Max Peters,Manit Arya,Manit Arya,Manit Arya,Naveed Afzal,Susan C. Charman,Tim Dudderidge,Feargus Hosking-Jervis,Feargus Hosking-Jervis,Richard Hindley,Henry Lewi,Neil McCartan,Neil McCartan,Caroline M. Moore,Caroline M. Moore,Raj Nigam,Chris Ogden,Raj Persad,Karishma Shah,Jan van der Meulen,Jaspal Virdi,Mathias Winkler,Mark Emberton,Mark Emberton,Hashim U. Ahmed,Hashim U. Ahmed,Hashim U. Ahmed +28 more
TL;DR: Focal HIFU therapy for patients with clinically significant prostate cancer that has not spread has a low probability of side effects and is effective at 5 yr, according to a multicentre study of 625 patients undergoing focal therapy using high-intensity focused ultrasound (HIFU).
293
Bedside teaching in medical education: a literature review.
Max Peters,Olle ten Cate +1 more
TL;DR: Impediments to bedside teaching need to be overcome if this teaching modality is to remain a valuable educational method for durable clinical skills.
282
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry
Taimur T. Shah,Taimur T. Shah,Taimur T. Shah,Max Peters,David Eldred-Evans,Saiful Miah,Saiful Miah,Saiful Miah,Tet Yap,Nicholas A. Faure-Walker,Feargus Hosking-Jervis,Benjamin Thomas,Tim Dudderidge,Richard Hindley,Stuart McCracken,Damian Greene,Raj Nigam,Massimo Valerio,Suks Minhas,Mathias Winkler,Manit Arya,Hashim U. Ahmed,Hashim U. Ahmed +22 more
TL;DR: Focal cryotherapy primarily for anterior intermediate and high-risk prostate cancer results in good rates of cancer control and low rates of treatment-related side effects andLimitations include lack of long-term outcomes.
129
Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Geert O. Janssens,Lorenza Gandola,Stéphanie Bolle,Henry Mandeville,Monica Ramos-Albiac,Karen Van Beek,Helen Benghiat,Bianca A.W. Hoeben,Andres Morales La Madrid,Rolf-Dieter Kortmann,Darren Hargrave,Johan Menten,Emilia Pecori,Veronica Biassoni,André O. von Bueren,Dannis G. van Vuurden,Maura Massimino,Dominik Sturm,Max Peters,Christof M. Kramm +19 more
TL;DR: The majority of patients with DIPG, responding to upfront radiotherapy, do benefit of re-irradiation with acceptable tolerability, and clinical improvement with re-IRradiation was observed in 24/31 (77%) patients.
128
The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis
Pim J.J. Damen,Tiuri E. Kroese,Richard van Hillegersberg,Ewoud Schuit,Ewoud Schuit,Max Peters,Joost J.C. Verhoeff,Steven H. Lin,Peter S.N. van Rossum +8 more
TL;DR: In this article, a systematic review and meta-analysis of the prognostic impact of radiation-induced lymphopenia (RIL) on OS in patients with solid tumors was conducted.
89